Liquid Biopsy in Early-Stage Lung Cancer: Current and Future Clinical Applications

SIMPLE SUMMARY: Early-stage disease non-small cell lung cancer has better outcomes than advanced disease, but 5-year survival rates can drop to approximately 50% in cases of increased tumor size, local extension, or nodal spread. The use of liquid biopsies to enhance diagnosis, optimize perioperativ...

Descripción completa

Detalles Bibliográficos
Autores principales: Vandekerckhove, Olivia, Cuppens, Kristof, Pat, Karin, Du Pont, Bert, Froyen, Guy, Maes, Brigitte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216452/
https://www.ncbi.nlm.nih.gov/pubmed/37345038
http://dx.doi.org/10.3390/cancers15102702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216452/
https://www.ncbi.nlm.nih.gov/pubmed/37345038
http://dx.doi.org/10.3390/cancers15102702

Ejemplares similares